Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by WaynerBob10 on Feb 26, 2021 10:47am

Once red

I've been holding for a couple of years now.  What has me concerned and why I think the price has taken a beating is the warrants.  Who here feels that $7.50 in three years is reasonable.  The stock touched $7.52 prior to the bought deal.  So many posters here were throwing numbers like $30, $40, $50 dollars a share.  New drug development companies are high risk high reward. $7.50 a share in three years time is to small a reward for the risk. So either this was a very bad deal or a deal to benefit Canacord and other nsiders at the expense of regular shareholders or worse the board of antibe have much lower expectations for future monetization then shareholders had.
Comment by clubhouse19 on Feb 26, 2021 10:52am
If this deal is on the up and up...you can be sure that the clients of the inderwriters are pissed and feel had.  But if you hear nothing,,,they are part of it and the collusion is very well possible.
Comment by Candyswanwick on Feb 26, 2021 11:17am
This is par for the course with a drug development company. The high reward was selling last time the stock kissed .80 earlier in 2020 after being 0.2-0.3 for an extended period of time. There was just another 100% gain within the last 2 months you could've sold?  This is what happens with drug development companies going through the phases of bringing a drug to market.. If you were ...more  
Comment by Candyswanwick on Feb 26, 2021 11:21am
Like seriously zoom out. If you're upset about returns over the last 5 years then nothing will make you happy. If you someone that chased a gap up after a news release in a drug development company, then you're a simp. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities